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Introduction
Malignant rhabdoid tumor, initially reported in the kid-
neys and thought to be a variant of  Wilms tumor, is an un-
common and highly aggressive tumor with a poor 
prognosis. Ever since its recognition as a distinct clinical 
entity, it has been described in the brain, chest, and extra-
renal abdominopelvic organs. We report a case of  primary 
hepatic malignant rhabdoid tumor, present the imaging 
and pathology findings, and briefly discuss the differential 
diagnosis.
Case report
   A 3-month-old female presented to her primary care phy-
sician with new-onset bilious emesis. Her family noticed a 
“funny shape” to her abdomen. Past medical history was 
positive for maternal gestational diabetes mellitus and tran-
sient neonatal jaundice. On physical exam, her abdomen 
was asymmetric, with firm swelling in the right upper 
quadrant. 
Abdominal ultrasound demonstrated a large, complex cys-
tic mass with unclear organ of  origin (Fig. 1). Subsequent 
CT confirmed a large, septated, predominantly cystic mass 
within the right hepatic lobe (Fig. 2, A and B). The poste-
rior margin of  the mass was ill-defined. The mass dis-
placed, but did not invade, the surrounding bowel and ret-
roperitoneal structures. On MRI, there was a mildly en-
hancing solid component at the posterior-inferior aspect of  
the mass (Fig. 3). Alpha-fetoprotein was mildly elevated at 
678 ng/ml (age-adjusted reference range of  3 - 417 
ng/ml). As the mass was mostly cystic, the primary consid-
eration was mesenchymal hamartoma. The presence of  a 
solid enhancing component suggested malignant degenera-
tion or an undifferentiated embryonal sarcoma. 
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Figure 1. Color Doppler ultrasound image of the abdomen demon-
strates a complex cystic mass of unclear organ of origin.
At laparotomy, a cystic mass was seen arising from the 
inferior right hepatic lobe without invasion of  adjacent 
organs (Fig. 4). More than 200 ml of  thick yellow-brown 
fluid was drained. The superior and lateral walls of  the 
mass were clearly separated from normal hepatic paren-
chyma. Medially, the mass extended almost to the level of  
the falciform ligament. A solid component was identified 
along the posterior-lateral wall of  the mass. This portion of 
the mass could not be completely dissected from hepatic 
parenchyma. 
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Figure 2, A and B. Axial and sagittal contrast-enhanced CT images 
delineate the intrahepatic location of the mass, which causes dis-
placement of the surrounding peritoneal and retroperitoneal 
structures. The posterior margin is irregular and ill-defined.
Figure 3.  Axial MRI subtraction image demonstrates a mildly en-
hancing component (arrow) along the posterior margin of the he-
patic mass.
Figure 4. Intraoperative photo of the mass (arrow).  
Figure 5.  Histologic slide reveals an area filled entirely with epithe-
lioid cells that demonstrate rhabdoid morphology (polygonal shape, 
dense eosinophilic cytoplasm, and eccentric nuclei). 
Figure 6. Immunohistochemical stain for INI-1 demonstrates diffuse 
loss of expression of this protein in the tumor cell nuclei, in contrast 
to strong INI-1 nuclear staining in the fibrous tissue to the right 
(arrows).
Histologic sections revealed a heterogeneous and highly 
cellular mass with hyperchromatic nuclei and frequent 
mitoses. There were areas of  fibrosis and cystic 
changes. The mass also contained epithelioid cells with 
rhabdoid morphology (Fig. 5). Immunohistochemistry 
showed lack of  muscle markers and diffuse loss of  nuclear 
INI-1 protein expression (Fig. 6). These features are most 
compatible with malignant rhabdoid tumor. Further 
workup demonstrated no evidence of  metastatic 
disease. The patient was started on chemotherapy and un-
derwent right hepatic lobectomy.
Discussion
   Malignant rhabdoid tumors were originally described 
as a highly aggressive variant of  Wilms tumors (1). They 
were so named due to their histologic resemblance to 
rhabdomyoblasts. Subsequent studies failed to confirm my-
ogenic differentiation (2). Following lack of  response to 
standard treatment regimens for Wilms tumors, they gained 
recognition as a distinct entity (3). Since then, malignant 
rhabdoid tumors have also been reported in extrarenal lo-
cations, including the central nervous system, liver, pelvis, 
chest, jejunum, and adrenal glands. The precise histiogene-
sis has not yet been elucidated (4).  
Primary hepatic malignant rhabdoid tumors are ex-
tremely rare. To the best of  our knowledge, 28 cases have 
been previously reported in the literature. The median age 
of  presentation was 8 months, with most patients below 2 
years of  age. Clinically, patients are often asymptomatic 
until the lesions become large. Symptoms are nonspecific 
and include abdominal pain, anorexia, and weight loss (4, 
5). On imaging, malignant rhabdoid tumors are large and 
heterogeneous. In one review of  the imaging features of  14 
cases, the median long-axis measurement was 10.6 cm (5). 
Occasionally, cystic changes and calcifications are 
present. In cases of  rupture, peritumoral hematoma can be 
seen (4, 5). Due to their nonspecific imaging findings and 
rarity, diagnostic considerations are often given to more 
common hepatic masses. Alpha-fetoprotein is normal in 
most cases.  
The differential diagnosis for a hepatic malignant rhab-
doid tumor primarily includes hepatoblastoma, hepatocel-
lular carcinoma, and undifferentiated embryonal 
sarcoma. Hepatoblastoma occurs in young patients, with 
70% of  cases occurring in children less than 2 years old. 
On imaging, hepatoblastomas usually appear as heteroge-
neously enhancing solid masses. Alpha-fetoprotein is ele-
vated in more than 90 percent of  cases. In our patient, the 
mass was predominantly cystic; the alpha-fetoprotein level 
was only mildly elevated, below the level typically seen with 
hepatoblastoma (6). Hepatocellular carcinoma is usually 
seen in older children (5-15 yo); elevated alpha-fetoprotein 
occurs in half  of  these patients. Undifferentiated embryo-
nal sarcoma (also known as malignant mesenchymoma) is 
most often seen in older children and is not associated with 
elevated alpha-fetoprotein. When the mass is predomi-
nantly cystic, the possibility of  mesenchymal hamartomas 
may be considered. These are seen in young children who 
have normal alpha-fetoprotein levels. Although these 
masses are benign, they can rarely undergo malignant de-
generation (7).
On histology, this patient’s hepatic mass was hypercellu-
lar and pleomorphic. It contained regions of  small round 
blue cells and large epithelioid cells with rhabdoid mor-
phology. The diagnosis was confirmed by immunohisto-
chemistry. The cells were negative for alpha-fetoprotein, a 
marker that is seen with hepatoblastoma and hepatocellular 
carcinoma. In a pattern typical of  rhabdoid tumors, the 
cells demonstrated a lack of  muscle markers and a loss of  
nuclear INI-1 protein. The latter is reasonably specific for 
rhabdoid tumor, due to its association with mutations of  
the tumor-suppressor gene hSNF5/INI-1. Treatment op-
tions for rhabdoid tumors include surgery, chemotherapy, 
liver transplant, or a combination of  these. Unfortunately, 
70 percent of  patients have metastatic disease on initial 
presentation, most commonly in the lungs and lymph 
nodes. The prognosis is generally poor, with a median sur-
vival time of  2 months (5). 
We present the radiologic and pathologic features of  
hepatic malignant rhabdoid tumor in an infant. Although 
rare, it should be recognized as an aggressive malignancy 
with dismal prognosis and high risk of  metastatic 
disease. This case underscores the importance of  consider-
ing this entity when the combination of  imaging, clinical, 
and laboratory findings does not fit one of  the more com-
mon hepatic lesions.
References
1. 	 Beckwith JB, Palmer NF. Histopathology and progno-
sis of  Wilms tumors: results from the First National 
Wilms' Tumor Study. Cancer. 1978;41(5):1937-48. 
[PubMed]
2. 	 Peng HQ, Stanek AE, Teichberg S, Shepard B, Kahn 
E. Malignant rhabdoid tumor of  the kidney in an 
adult: a case report and review of  the literature. Arch 
Path & Lab Med. 2003;127(9):e371-3. [PubMed]
3. 	 Palmer NF, Sutow W. Clinical aspects of  the rhabdoid 
tumor of  the kidney: a report of  the National Wilms' 
Tumor Study Group. Med and Ped Oncol. 
1983;11(4):242-5. [PubMed]
4. 	 Sibileau E, Moroch J, Teyssedou C, Aube C. Malig-
nant rhabdoid tumors of  the liver: an exceptional tu-
mor in adults - a case report and literature review. Eur 
J Gastroenterol & Hepat. 2011;23(1):104-8. [PubMed]
5. 	 Abe T, Oguma E, Nozawa K, et al. Malignant rhab-
doid tumor of  the liver: a case report with US and CT 
manifestation. Jap J Radiol 2009;27(10):462-5. [Pub-
Med]
6. 	 Blohm ME, Vesterling-Horner D, Calaminus G, Gobel 
U. Alpha 1-fetoprotein (AFP) reference values in in-
fants up to 2 years of  age. Ped Hematol & Oncol. 
1998;15(2):135-42. [PubMed]
7. 	 Ramanujam TM, Ramesh JC, Goh DW, et al. Malig-
nant transformation of  mesenchymal hamartoma of  
the liver: case report and review of  the literature. J Ped 
Surg. 1999;34(11):1684-6. [PubMed]
Malignant rhabdoid tumor of the liver: Findings at US, CT, and MRI, with histopathologic correlation
RCR Radiology Case Reports | radiology.casereports.net! 3! 2014 | Volume 9 | Issue 1
